Based on the strong effects of GSK-3β inhibition on the stem/progenitor cell subpopulation in vitro, we evaluated the effects of GIN pretreatment on prostate cancer tumorigenicity and metastatic potential in vivo. The gene discussed is GSK3B; the disease is Familial prostate cancer.